1. Home
  2. ACU vs NKTX Comparison

ACU vs NKTX Comparison

Compare ACU & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACU
  • NKTX
  • Stock Information
  • Founded
  • ACU 1867
  • NKTX 2015
  • Country
  • ACU United States
  • NKTX United States
  • Employees
  • ACU N/A
  • NKTX N/A
  • Industry
  • ACU Industrial Machinery/Components
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACU Consumer Discretionary
  • NKTX Health Care
  • Exchange
  • ACU Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • ACU 145.9M
  • NKTX 123.5M
  • IPO Year
  • ACU N/A
  • NKTX 2020
  • Fundamental
  • Price
  • ACU $43.23
  • NKTX $1.72
  • Analyst Decision
  • ACU
  • NKTX Strong Buy
  • Analyst Count
  • ACU 0
  • NKTX 6
  • Target Price
  • ACU N/A
  • NKTX $14.40
  • AVG Volume (30 Days)
  • ACU 35.4K
  • NKTX 502.7K
  • Earning Date
  • ACU 07-18-2025
  • NKTX 08-12-2025
  • Dividend Yield
  • ACU 1.40%
  • NKTX N/A
  • EPS Growth
  • ACU N/A
  • NKTX N/A
  • EPS
  • ACU 2.48
  • NKTX N/A
  • Revenue
  • ACU $195,491,991.00
  • NKTX N/A
  • Revenue This Year
  • ACU $4.87
  • NKTX N/A
  • Revenue Next Year
  • ACU $3.65
  • NKTX N/A
  • P/E Ratio
  • ACU $17.30
  • NKTX N/A
  • Revenue Growth
  • ACU 2.56
  • NKTX N/A
  • 52 Week Low
  • ACU $32.85
  • NKTX $1.31
  • 52 Week High
  • ACU $50.00
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • ACU 62.35
  • NKTX 40.24
  • Support Level
  • ACU $38.87
  • NKTX $1.70
  • Resistance Level
  • ACU $41.67
  • NKTX $1.84
  • Average True Range (ATR)
  • ACU 1.17
  • NKTX 0.08
  • MACD
  • ACU 0.33
  • NKTX -0.02
  • Stochastic Oscillator
  • ACU 95.15
  • NKTX 10.98

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: